Peak Hours News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Economy

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by January 19, 2025
written by January 19, 2025

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS

0 comment
0
FacebookTwitterPinterestEmail

previous post
IMF’s board approves second review of Ethiopia’s $3.4 billion program
next post
Israel stocks higher at close of trade; TA 35 up 1.07%

You may also like

A flagging U.S. industry looks for new life...

July 18, 2025

Coca-Cola dodges after Trump says soda will switch...

July 18, 2025

Trump says it’s ‘highly unlikely’ he will fire...

July 17, 2025

Inflation picks up again in June as tariffs...

July 16, 2025

Jerome Powell asks inspector general to review Fed’s...

July 15, 2025

Some Walmart garment orders from Bangladesh on hold...

July 13, 2025

Italian chocolate giant Ferrero to buy Kellogg’s Froot...

July 11, 2025

White House accuses Powell of mismanaging Federal Reserve,...

July 11, 2025

Trump’s tariffs on Brazil could make your coffee...

July 11, 2025

Sports executive charged with bid-rigging in Texas arena...

July 10, 2025
Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.









    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 18, 2025
    • Coca-Cola dodges after Trump says soda will switch back to cane sugar

      July 18, 2025
    • A flagging U.S. industry looks for new life in a Philadelphia shipyard

      July 18, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 17, 2025
    • Trump says it’s ‘highly unlikely’ he will fire Fed Chair after broaching idea with GOP reps

      July 17, 2025

    Categories

    • Economy (521)
    • Editor's Pick (10)
    • Investing (923)
    • Stock (798)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: peakhoursnews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Back To Top
    Peak Hours News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick